These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 32781560

  • 1. Highly Sensitive and Specific Molecular Test for Mutations in the Diagnosis of Thyroid Nodules: A Prospective Study of BRAF-Prevalent Population.
    Cho YY, Park SY, Shin JH, Oh YL, Choe JH, Kim JH, Kim JS, Yim HS, Kim YL, Ki CS, Kim TH, Chung JH, Kim SW.
    Int J Mol Sci; 2020 Aug 06; 21(16):. PubMed ID: 32781560
    [Abstract] [Full Text] [Related]

  • 2. BRAFV600E mutation test on fine-needle aspiration specimens of thyroid nodules: Clinical correlations for 4600 patients.
    Chen H, Song A, Wang Y, He Y, Tong J, Di J, Li C, Zhou Z, Cai X, Zhong D, Da J.
    Cancer Med; 2022 Jan 06; 11(1):40-49. PubMed ID: 34851044
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the Clinical Validity of Droplet Digital PCR to ARMS-PCR for BRAF V600E Mutation Detection in Thyroid Nodules.
    Li X, Du H, Luo J, Ding W, Lai B, He J, Xu S, Zhang Y.
    J Clin Lab Anal; 2020 Nov 06; 34(11):e23458. PubMed ID: 32671901
    [Abstract] [Full Text] [Related]

  • 4. Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area.
    Chung KW, Yang SK, Lee GK, Kim EY, Kwon S, Lee SH, Park DJ, Lee HS, Cho BY, Lee ES, Kim SW.
    Clin Endocrinol (Oxf); 2006 Nov 06; 65(5):660-6. PubMed ID: 17054470
    [Abstract] [Full Text] [Related]

  • 5. Clinical implication of highly sensitive detection of the BRAF V600E mutation in fine-needle aspirations of thyroid nodules: a comparative analysis of three molecular assays in 4585 consecutive cases in a BRAF V600E mutation-prevalent area.
    Lee ST, Kim SW, Ki CS, Jang JH, Shin JH, Oh YL, Kim JW, Chung JH.
    J Clin Endocrinol Metab; 2012 Jul 06; 97(7):2299-306. PubMed ID: 22500044
    [Abstract] [Full Text] [Related]

  • 6. BRAF V600E mutation analysis of thyroid nodules needle aspirates in relation to their ultrasongraphic classification: a potential guide for selection of samples for molecular analysis.
    Nam SY, Han BK, Ko EY, Kang SS, Hahn SY, Hwang JY, Nam MY, Kim JW, Chung JH, Oh YL, Shin JH.
    Thyroid; 2010 Mar 06; 20(3):273-9. PubMed ID: 20187782
    [Abstract] [Full Text] [Related]

  • 7. Diagnostic Value and Challenges of BRAF V600E Molecular Testing and Thyroid Fine-Needle Aspiration Cytology: A Retrospective Study from a Tertiary Institution in Southern Hunan Province, China.
    Lan Z, Yang F, Zhang J, Lan Y, Li H, He R.
    Acta Cytol; 2023 Mar 06; 67(6):629-638. PubMed ID: 37708867
    [Abstract] [Full Text] [Related]

  • 8. Detection of BRAF c.1799T > A (p.V600E) mutation using residual routine fine-needle aspiration specimens of papillary thyroid carcinoma.
    Zhao H, Zhang ZH, Zhou B, Xiao T, Pan QJ, Guo HQ.
    Diagn Cytopathol; 2015 Oct 06; 43(10):786-90. PubMed ID: 26152656
    [Abstract] [Full Text] [Related]

  • 9. Fine-needle Aspiration Washout Precipitation Specimens: An Acceptable Supplement to Genetic Mutation Detection of Thyroid Nodules.
    Cui Y, Huang X, Guo J, Zhang N, Liang J, Zhang Y, Liao Y, He D.
    Technol Cancer Res Treat; 2021 Oct 06; 20():15330338211057982. PubMed ID: 34806478
    [Abstract] [Full Text] [Related]

  • 10. Allele-specific PCR with competitive probe blocking for sensitive and specific detection of BRAF V600E in thyroid fine-needle aspiration specimens.
    Smith GD, Zhou L, Rowe LR, Jarboe EA, Collins BT, Bentz JS, Wittwer CT, Chadwick BE.
    Acta Cytol; 2011 Oct 06; 55(6):576-83. PubMed ID: 22156469
    [Abstract] [Full Text] [Related]

  • 11. Value of BRAF V600E in High-Risk Thyroid Nodules with Benign Cytology Results.
    Chen X, Zhou Q, Wang F, Zhang F, Du H, Zhang Q, Wu W, Gong X.
    AJNR Am J Neuroradiol; 2018 Dec 06; 39(12):2360-2365. PubMed ID: 30498021
    [Abstract] [Full Text] [Related]

  • 12. The mutational analysis in the diagnostic work-up of thyroid nodules: the real impact in a center with large experience in thyroid cytopathology.
    Macerola E, Rago T, Proietti A, Basolo F, Vitti P.
    J Endocrinol Invest; 2019 Feb 06; 42(2):157-166. PubMed ID: 29704233
    [Abstract] [Full Text] [Related]

  • 13. Contribution of the BRAF mutation analysis in calcified thyroid nodules.
    Yoo EY, Shin JH, Ko EY, Han BK.
    AJR Am J Roentgenol; 2012 Apr 06; 198(4):891-5. PubMed ID: 22451557
    [Abstract] [Full Text] [Related]

  • 14. Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules.
    Nikiforov YE, Steward DL, Robinson-Smith TM, Haugen BR, Klopper JP, Zhu Z, Fagin JA, Falciglia M, Weber K, Nikiforova MN.
    J Clin Endocrinol Metab; 2009 Jun 06; 94(6):2092-8. PubMed ID: 19318445
    [Abstract] [Full Text] [Related]

  • 15. Initial clinical experience with BRAF(V600E) mutation analysis of core-needle biopsy specimens from thyroid nodules.
    Choi SH, Baek JH, Lee JH, Choi YJ, Ha EJ, Song DE, Kim JK, Chung KW, Kim TY, Kim WB, Shong YK.
    Clin Endocrinol (Oxf); 2016 Apr 06; 84(4):607-13. PubMed ID: 26215382
    [Abstract] [Full Text] [Related]

  • 16. What to do with thyroid nodules showing benign cytology and BRAF(V600E) mutation? A study based on clinical and radiologic features using a highly sensitive analytic method.
    Kim SY, Kim EK, Kwak JY, Moon HJ, Yoon JH.
    Surgery; 2015 Feb 06; 157(2):354-61. PubMed ID: 25616949
    [Abstract] [Full Text] [Related]

  • 17. Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples.
    Nikiforov YE, Ohori NP, Hodak SP, Carty SE, LeBeau SO, Ferris RL, Yip L, Seethala RR, Tublin ME, Stang MT, Coyne C, Johnson JT, Stewart AF, Nikiforova MN.
    J Clin Endocrinol Metab; 2011 Nov 06; 96(11):3390-7. PubMed ID: 21880806
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic Limitation of Fine-Needle Aspiration (FNA) on Indeterminate Thyroid Nodules Can Be Partially Overcome by Preoperative Molecular Analysis: Assessment of RET/PTC1 Rearrangement in BRAF and RAS Wild-Type Routine Air-Dried FNA Specimens.
    Ko YS, Hwang TS, Kim JY, Choi YL, Lee SE, Han HS, Kim WS, Kim SK, Park KS.
    Int J Mol Sci; 2017 Apr 12; 18(4):. PubMed ID: 28417935
    [Abstract] [Full Text] [Related]

  • 19. Pilot of BRAF mutation analysis in indeterminate, suspicious and malignant thyroid FNA cytology.
    Johnson SJ, Hardy SA, Roberts C, Bourn D, Mallick U, Perros P.
    Cytopathology; 2014 Jun 12; 25(3):146-54. PubMed ID: 24417615
    [Abstract] [Full Text] [Related]

  • 20. Testing for BRAF (V600E) Mutation in Thyroid Nodules with Fine-Needle Aspiration (FNA) Read as Suspicious for Malignancy (Bethesda V, Thy4, TIR4): a Systematic Review and Meta-analysis.
    Trimboli P, Scappaticcio L, Treglia G, Guidobaldi L, Bongiovanni M, Giovanella L.
    Endocr Pathol; 2020 Mar 12; 31(1):57-66. PubMed ID: 31811566
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.